MIGRAINE BY PROF, AZZA EL-MEDANY MIGRAINE Recurrent attacks of headache. Unilateral, associated with migraine aura ( anorexia, nausea, vomiting, visual.

Slides:



Advertisements
Similar presentations
Other Medicines. Andrenergic Antagonists (Blockers) Bind to receptor site but do not cause an action Bind to receptor site but do not cause an action.
Advertisements

Headache.
Acute treatment of migraine Mark Weatherall BASH meeting, Hull 2009.
N ON - STEROIDAL ANTI - INFLAMMATORY DRUGS. BY PROF. AZZA EL-MEDANY DR. OSAMA YOUSIF.
Headaches - In Primary Care Dr M Banerjee GP Registrar Tadworth.
1 Copyright © 2012, 2008, 2002, 1998, 1994, 1989, 1984, 1978 by Mosby, Inc., an affiliate of Elsevier Inc. Reminder:  QUIZ NEXT WEEK ON:  Anti-infectives,
Migraine Lecture 2002 Jin-Hyeun Huh Pharmacy Practice Leader TWH, UHN.
 Migraine is a benign and recurring syndrome of headache, nausea and vomiting, and /or other neurological dysfunction.  Migraine, the most common cause.
Migraines Mark Green, MD Clinical Professor Department of Neurology Columbia University New York, NY.
Vishal Sharma. Overview  Migraine and Statistics  History  Classification and symptoms  Etiology and Pathophysiology  Treatment.
Prof. Omnia Amin Nayel & Dr. Ishfaq Bukhari. Differentiate between types of headache regarding their symptoms, signs and pathophysiology. Recognize drugs.
Prof. Omnia Amin Nayel & Dr. Ishfaq Bukhari. Differentiate between types of headache regarding their symptoms, signs and pathophysiology. Recognize drugs.
Migraine Headaches Jim Ducharme MD CM FRCP Professor, Emergency Medicine Dalhousie University.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 18 Autocoids and Antihistamines.
Differentiate between types of headache regarding their symptoms, signs and pathophysiology. Recognize drugs used to prevent migraine Identify drugs used.
Anti-migraine Drugs Courtney Geiger Medicinal Chemistry Dr. Buynak November 18, 2004.
8/14/20151 MIGRAINE DR.ABDUL LATIF MAHESAR Department of medical pharmacology KING SAUD UNIVERSITY 1March 2011.
Ehab Samara Fedaa Matanes. Pain concentrated on one side of the head A debilitating neurobiological headache disorder Affects 28 million people in the.
Anti-Migraine Drugs Brian Lich April 3 rd, Overview Migraines: What are they? Symptoms? Causes? Migraines: What are they? Symptoms? Causes? History:
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 30 Drugs for Headache.
Acute treatment of migraine Dr Mark Weatherall London Headache Centre 2010.
“My migraine always comes back” Presented by: Julio Pascual Neuroscience Area, Service of Neurology, University Hospital Central de Asturias and Ineuropa,
Neurology Lecture 4a Headaches.
Migraine Headaches Migraine Severe, throbbing, vascular headache
Serotonin or 5-hydroxytryptamine Widely distributed amine (animals + plants) In humans, present in GI enterochromaffin cells (90%), platelets and brain.
School of Clinical Medicine School of Clinical Medicine UNIVERSITY OF CAMBRIDGE Headache Jane Smith, a 23 year old woman, presents to her GP complaining.
Dr.B.V.Venkataraman Professor in Pharmacology Faculti Perubatan, Shah Alam, Malaysia Ph: /
 Migraine can usually be distinguished clinically from the two other common types of headaches—cluster headache and tension-type headache—by its characteristics.
N ON - STEROIDAL ANTI - INFLAMMATORY DRUGS. OBJECTIVES At the end of the lecture the students should : Define NSAIDs Describe the classification of this.
Prof. Omnia Amin Nayel & Dr. Abdul latif Mahesar.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 6 Nonopiod (Nonnarcotic) Analgesics.
OBJECTIVES At the end of lectures the students should Describe the different classes of drugs used for treatment of acute & chronic heart failure.
Mechanism of action It interacts with specific receptors in the CNS, particularly in the cerebral cortex. Benzodiazepine-receptor binding enhances the.
1 Drug Treatment of heart failure. Prof. Azza El-Medani Prof. Abdulrahman Almotrefi.
Migraine Headaches Migraine – Severe, throbbing, vascular headache – Recurrent unilateral head pain – Combined with neurologic and GI disturbances.
PROF. AZZA El-Medany Department of Pharmacology OBJECTIVES At the end of lectures the students should Describe the different classes of drugs used for.
Slow Acting Anti-inflammatory Drugs ). BY PROF. AZZA EL-MEDANY DR. OSAMA YOUSF.
Prepared By MARIAM SALEH ALAMRO A Calcium Channel Blocker.
Serotonin ( 5- hydroxy tryptamine; 5HT ). Serotonin ( 5- hydroxy tryptamine; 5HT ) Locations: Locations: - Gut enterochromaffin cells ( 90% ) - Gut enterochromaffin.
Ergot Alkaloids Dr. Naila Abrar. LEARNING OBJECTIVES After this session, you should be able to: know the source and classification of ergot alkaloids;
DRUGS RELATED TO BALANCE
ERYTHROPOIESIS- STIMULATING AGENTS. Patients who are no longer able to produce enough erythropoietin in the kidneys may benefit from treatment with.
Miscellaneous Pain Medications Medications for Pain & Inflammation ADN 110/cohort 131.
Prof. Omnia Amin Nayel & Dr. Ishfaq Bukhari
Angina pectoris Sudden,severe,pressing chest pain starting substernal &radiate to left arm & neck. Due to imbalance between myocardium oxygen requirement.
- nonsteroidal anti-inflammatory drugs (NSAIDs), are used to combat inflammation. - Their antiinflammatory action equals that of aspirin. - have analgesic.
Drugs in parkinsonism ilos
Dublin November 13 th 2011 By Dr. Edward O’Sullivan 13-Nov
Dr. Ishfaq Bukhari. Differentiate between types of headache regarding their symptoms, signs and pathophysiology. Recognize drugs used to prevent migraine.
Adrenergic Antagonists
Sympatholytic & adrenergic blockers -receptor Antagonists
Treatment of migraine headache. Introduction Migraine is a severe type of unilateral periodic headache characterized by: 1.Prodorme 2.Aura: mild headache,
Non-steroidal anti-inflammatory drugs
MANAGAMENT OF MIGRAINE. Migraine Facts Migraine is one of the common causes of recurrent headaches Migraine is one of the common causes of recurrent headaches.
Headaches Jo Swallow ST1s May 2009.
Structures rich in 5-HT GIT (chromaffin cells and enteric neurons)
Drugs for Headaches 1.
Department of Pharmacology
DRUGS USED IN HEADACHE AND MIGRAINE
Migraine headache is characterized by unilateral , throbbing or non throbbing headache , associated with nausea, vomiting ,photophobia and phonophobia.
Migraine Headaches Migraine Severe, throbbing, vascular headache
DRUGS USED IN HEADACHE AND MIGRAINE
Reflux esophagitis.
Drugs used in headache and migraine
Dopamine receptor agonists
β – ADRENERGIC BLOCKERS
Dr. Aliah Alshanwani Dr. Ishfaq Bukhari Oct 2018
School of Pharmacy, University of Nizwa
DRUGS USED IN HEADACHE AND MIGRAINE
Non opioids pain management
Presentation transcript:

MIGRAINE

BY PROF, AZZA EL-MEDANY

MIGRAINE Recurrent attacks of headache. Unilateral, associated with migraine aura ( anorexia, nausea, vomiting, visual or auditory disturbances ). Common in young female. Pulsating or throbbing in character. Sustain for more than 2 hours. Affect about 10-20% of population

RISK FACTORS PHYSICAL Fatigue, Fasting,Exercise PSYCHOLOGICAL Stress, Anxiety, Depression DISEASES Hypertension,Fever

CONTINUE HORMONAL Menstruation, Menopause,Oral contraceptive pills. DIET Cheese, Chocolate,Alcohol CLIMATIC FACTORS Temperature changes

VASCULAR THEORY PHASE ( 1) :: V.C. of intra& extracranial b.v. may be due to release of 5HT from platelet or mast cells. Migraine aura occurs in this phase. PHASE (2): V.D. of intra & extracranial b.v. may be due to release of neurotransmitters as substance P,or neurokinins. PHASE (3) : Inflammatory reactions due to liberation of inflammatory mediators

Cassification Of Migraine Mild Moderate Severe

(Cont.) MILD One attack /month Normal daily activities continue. MODERATE One or two attacks / month Normal daily activities may or not continue.

CONTINUE SEVERE More than 3 attacks / month Normal activities cannot continue. Patients treated with both acute & prophylactic medications.

Drugs used in acute attack NSAIDS ANTIEMETICS ERGOT ALKALOIDS TRIPTAN CLASS

NSAID,s Inhibits prostaglandins synthesis centrally. Antiemetic drugs are usually added to increase their absorption. No withdrawal symptoms on sudden withdrawal. Main adverse effects Gastric Upset.

ANTIEMETICS e.g. Metoclopramide, Domperidone They are dopamine receptors antagonist. Given at the onset of the attack as adjunctive therapy to reduce gastric symptoms ( N.& V.). To improve oral absorption of analgesics

ERGOT ALKALOIDS Ergotamine Dihydroergotamine They act as partial agonists ( Agonist & Antagonist) at adrenergic, dopaminergic & serotonergic (5- HT 1 B/ 1 D)receptors.

N.B. Patients advised to take ergot preparations at the earliest sign of a migrain attack for the maximal benefit. Their main pharmacological effect is V.C. either centrally or peripherally.

PHRMACOKINETICS Ergotamine can be given by all routes. Orally undergoes extensive 1 st pass metabolism. Sublingual has a bioavailability less than 1% Rectal route best method of absorption Nasal spray I.M., SC, I.V.

CONTINUE Usually given in combination with caffeine to facilitate its absorption. Long acting drug Cumulative drug. High tissue binding 90% of metabolites are excreted in the bile Its effect persist up to 24 hours.

CLINICAL USES Acute attack of migraine ( Moderate & Severe ).

ADVERSE EFFECTS Nausea, vomiting( direct effect on CNS emetic centre), diarrhea, abdominal pain. Coldness, numbness of fingers & toes. Prolonged use causes paresthesias, gangrene. Coronary vasospasm. Rebound headache ( V.D after V.C) CNS (hallucination)

CONTRAINDICATIONS Pregnancy Peripheral & coronary vascular diseases. Hypertension Impaired hepatic or renal diseases

CONTINUE In concurrent use with : TRIPTANS β- BLOCKERS In prophylaxis of migraine

TRIPTAN CLASS Triptans have selective agonist activity at 5-HT 1D & 1B subtype receptors. Unlike ergotamine, triptans are effective when given 4 hours or longer after the onset of the attack. They are more expensive than ergot.

MECHANISM OF ACTION Reducing the excitability of neurons in the trigeminovascular system via stimulation of brain stem 5-HT 1B/1D receptors. Attenuating the release of neuropeptides with inflammatory & vasodilating effect as substance P via 5- HT 1D receptors.

Continue Vasoconstriction of cerebral & extracerebral vessels by stimulation of vascular 5HT 1B receptors. N.B. Coronary artery contains 5-HT 1B receptors so they cause coronary vasoconstriction.

SUMATRIPTAN Selective agonist at 5-HT 1D&1B receptors.

PHRMACOKINETICS Orally undergoes 1 st pass hepatic metabolism.( bioavailability 14-17% S.C ( rapid absorption, peak in 12 min). Bioavailability 97%. I.V. Not given ( risky ). Nasal spray HALF-life 2 hrs.

ZOLMITRIPTAN Oral bioavailability (40%). Metabolized in liver to active metabolites which have a higher affinity to 5HT 1 B & 1 D receptors than the parent drug. Half- life for both 2-3hrs. Plasma protein binding 14%.

NARATRIPTAN Oral bioavailability 70%. Half-life 6 hrs ( longest). 50% excreted unchanged in urine. Plasma protein binding 30%.

CLINICAL USES Acute attack of migraine ( moderate & severe ). Acute cluster headache.

ADVERSE EFFECTS Mild pain & burning sensation at the site of injection. Paresthesia, warmth, heaviness in head or other parts of the body. Dizziness Hypertension Coronary artery vasospasm (anginal pain), MI, Ventricular arrhythmias. Bitter taste ( nasal spray)

CONTRAINDICATIONS Coronary vascular disease. Ischemic heart disease. Hypertension Concurrent use with ergotamine Concurrent use with β- blockers. Naratriptan is contraindicated in patients with severe renal or hepatic impairment.

PROPHYLAXIS OF MIGRAINE INDICATIONS Two or more attacks / month Acute symptomatic treatment is required more than 2-3 times/ week. Drugs used in acute attack are ineffective, intolerable or contraindicated.

CONTINUE Headache is severe and associated with neurological symptoms. Drugs used in prophylactic treatment need several weeks to manifest their effects. Treatment should continue for 6 months & can be repeated after a rest period.

DRUGS USED IN PROPHYLAXIS Methysergide Cyproheptadine & Pizotifen β- blockers Calcium channel blockers Antidepressant drugs Ondansetron

METHYSERGID 5HT 2A&C receptor antagonist. Anti-inflammatory effect. Mild V.C. effect. Given orally. Used only for prophylaxis treatment. Not used for more than 6 months, repeated after a holiday of one month.

SIDE EFFECTS Retroperitoneal, pericardial, pleural or valvular fibrosis ( mainly after prolonged use). Nausea,Vomiting, Diarrhea. Peripheral edema. CNS manifestations

CONTRAINDICATIONS With β- blockers. With ergot alkaloids. Valvular diseases Pregnancy

CYPROHEPTADINE & PIZOTIFEN Antiserotonergic ( 5HT 2A ) receptors. Antihistaminic ( H 1 ) receptors. Anticholinergic SIDE EFFECTS Vertigo, Drowsiness Increase body weight.

ONDANSETRON 5-HT 3 antagonist. Effective for prophylaxis of migraine. Effective in the treatment of chemotherapy induced nausea.

β- BLOCKERS Act through β- blocking effect on intra or extracranial blood vessels. Antiserotonergic effect.

CONTRAINDICATIONS Old age Bronchial asthma A-V block CHF

ANTIDEPRESSANTS TCA & SSRIs prevent the release of 5HT from brain mast cells. Prevent V.C. which trigger 1 st phase.

CALCIUM CHANNEL BLOCKERS Decrease severity & frequency of migraine through blocking the influx of calcium.